Gulf International Bank (UK)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Other funds holding HZNP
IA
BTI
VWA
FSWA
BCMLT
HNB
Gulf International Bank (UK)'s HZNP Position: Q4 2023 in Review
Gulf International Bank (UK) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 20,020 shares — an estimated $2.32M sold.
Gulf International Bank (UK) first reported a position in HZNP in Q4 2020 and held it in 12 quarters. The position peaked at $5.27M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.
- Gulf International Bank (UK) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
- Gulf International Bank (UK) sold 20,020 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.32M.
- Gulf International Bank (UK) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 12 quarters.
- Gulf International Bank (UK)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5.27M in Q3 2021.
- 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.
Based on Gulf International Bank (UK)'s 13F filing for Q4 2023, filed 11 Jan 2024.